These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7671440)

  • 1. Workshop on in vitro neurotoxicity testing: the obstacles, the way forward.
    Abdulla EM; Atterwill C; Campbell IC
    Clin Exp Pharmacol Physiol; 1995 Apr; 22(4):277-80. PubMed ID: 7671440
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotoxicity testing: a discussion of in vitro alternatives.
    Costa LG
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):505-10. PubMed ID: 9599699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cytoskeletal proteins in the mechanisms of organophosphorus ester-induced delayed neurotoxicity.
    Abou-Donia MB
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):358-9. PubMed ID: 7554428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of epinephrine in local anesthetics on the central and peripheral nervous systems: Neurotoxicity and neural blood flow.
    Neal JM
    Reg Anesth Pain Med; 2003; 28(2):124-34. PubMed ID: 12677623
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of action of central and peripheral antitussive drugs.
    Bolser DC
    Pulm Pharmacol; 1996; 9(5-6):357-64. PubMed ID: 9232675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurotoxicity of anti-infective agents].
    Christ W
    Med Monatsschr Pharm; 2000 Feb; 23(2):42-9. PubMed ID: 10701307
    [No Abstract]   [Full Text] [Related]  

  • 7. Invited editorial on "Femoral arterial injection of adenosine in humans elevates MSNA via central but not peripheral mechanisms".
    Kaufman MP
    J Appl Physiol (1985); 1997 Oct; 83(4):1043-4. PubMed ID: 9338408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activation of the cholinergic innervation in the treatment of diseases of the peripheral and central nervous system].
    Strokov IA; Zakharov VV; Golovacheva VA; Brand PIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):91-8. PubMed ID: 23951580
    [No Abstract]   [Full Text] [Related]  

  • 10. A human neuroblastoma cell line for neurotoxicity testing in vitro: effects of heavy metals.
    Clementi F; Cabrini D; Gotti C; Fornasari D; Sher E
    Prog Clin Biol Res; 1987; 253():137-49. PubMed ID: 3432283
    [No Abstract]   [Full Text] [Related]  

  • 11. Ganglioside GM1 and its semisynthetic lysogangliosides reduce glutamate neurotoxicity by a novel mechanism.
    Costa E; Armstrong D; Guidotti A; Kharlamov A; Kiedrowski L; Wroblewski JT
    Adv Exp Med Biol; 1993; 341():129-41. PubMed ID: 7906915
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological indicators of neurotoxicity in central and peripheral toxic neuropathies.
    Maroni M; Barbieri F
    Neurotoxicol Teratol; 1988; 10(5):479-84. PubMed ID: 3073308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological measurement of neurotoxic injury in the peripheral nervous system: preparation of material for light and transmission electron microscopic evaluation.
    Hancock SK; Hinckley J; Ehrich M; Jortner BS
    Curr Protoc Toxicol; 2005 Jan; Chapter 12():Unit12.12. PubMed ID: 23045109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the second meeting of the International Neurotoxicology Association. Sitges, Spain, May 22-26, 1989. Proceedings.
    Neurotoxicol Teratol; 1990; 12(6):573-681. PubMed ID: 2255300
    [No Abstract]   [Full Text] [Related]  

  • 15. Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).
    Petrini M; Vaglini F; Cervetti G; Cavalletti M; Sartucci F; Murri L; Corsini GU
    J Neural Transm (Vienna); 1999; 106(5-6):569-75. PubMed ID: 10443559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-amino-2-hydroxy-N-(4-nitrophenyl)-propanesulphonamide, a new class of GABAB receptor antagonist in central and peripheral preparations.
    Kerr DI; Ong J; Hughes R; Prager RH
    Eur J Pharmacol; 1995 Dec; 294(1):349-52. PubMed ID: 8788452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing neurotoxicity using the in vitro hippocampal brain slice preparation: heavy metals.
    Fountain SB; Teyler TJ
    Prog Clin Biol Res; 1987; 253():19-31. PubMed ID: 3432287
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological complications of cancer chemotherapy.
    Hildebrand J
    Curr Opin Oncol; 2006 Jul; 18(4):321-4. PubMed ID: 16721124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.
    Schmidt BZ; Lehmann M; Gutbier S; Nembo E; Noel S; Smirnova L; Forsby A; Hescheler J; Avci HX; Hartung T; Leist M; Kobolák J; Dinnyés A
    Arch Toxicol; 2017 Jan; 91(1):1-33. PubMed ID: 27492622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of peptide found in scorpion venom with neurodepressant effects in peripheral and central nervous system of the rat.
    Corona M; Coronas FV; Merino E; Becerril B; Gutiérrez R; Rebolledo-Antunez S; Garcia DE; Possani LD
    Biochim Biophys Acta; 2003 Jun; 1649(1):58-67. PubMed ID: 12818191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.